Dexcom G4 PLATINUM HCP Brochure

12
Stay One Step Ahead Exceptional Performance 1 and Protection with Dexcom Continuous Glucose Monitoring

description

Details for doctors on the new Dexcom G4 PLATINUM CGM system

Transcript of Dexcom G4 PLATINUM HCP Brochure

Page 1: Dexcom G4 PLATINUM HCP Brochure

Stay One Step Ahead Exceptional Performance1

and Protection with Dexcom Continuous Glucose Monitoring

Page 2: Dexcom G4 PLATINUM HCP Brochure

First and only CGM with single-digit MARD1 (Mean Absolute Relative

Difference).

Get the CGM that offers exceptional sensing performance.

Sleek, slim, and easy to see.The Dexcom G4 PLATINUM Continuous Glucose Monitoring

(CGM) System offers a modern design and a vibrant color

LCD screen so you can easily see glucose highs, lows and

everything in between to help manage your patients’ diabetes.

You’re serious about results, so don’t settle for just any sensor. Choose the one that delivers dynamic glucose patterns,

exceptional sensing performance2, and software that makes

identifying critical patterns quick and easy. Choose Dexcom

G4 PLATINUM and see the difference.

Tickled Pink

Classic Black

Ocean Blue

Page 3: Dexcom G4 PLATINUM HCP Brochure
Page 4: Dexcom G4 PLATINUM HCP Brochure

If your patients saw this instead, would they have responded differently?

If this was the meter reading, what would your patients do?

Even if your patients test frequently, a lot can happen between fingersticks. A number alone can’t tell you or your patients which way their glucose is headed and how fast it’s getting there.

With Dexcom CGM, patients can stop the guesswork and worries that come with making decisions based on a number. CGM allows you and your patients to make confident and informed decisions for optimal diabetes management.+

“My patient’s meter shows 120. He thinks he’s good to go!”

“My patient gets the same number but the end results are different.”

Sound familiar?

But is he really?

Speed and DirectionInforms Better Decisions

+ A minimum of 2 fingersticks a day is required for calibration. System may require more.

Page 5: Dexcom G4 PLATINUM HCP Brochure

Dexcom G4 PLATINUM allows patients to directly and

continuously link behavior to glycemic control. This

powerful knowledge can be integrated into a

comprehensive self-management regimen resulting in

consistent compliance, improved HbA1c, and a higher quality

of life.3

The Endocrine Society found that adult patients who have

elevated HbA1c levels of at least 7.0% and are using a CGM on

a daily basis had a greater reduction in HbA1c compared to

intermittent blood glucose meter readings.4

92%of patients report Dexcom CGM helped improve their overall quality of life3

The CGM Difference Improved Glycemic

Control 30% more time in the

optimal ADA range5

Improved HbA1c Levels Lower HbA1c with

no increase in hypoglycemia risk6

Optimal Diabetes Management

86% of Dexcom patients reported broad improvement in perceived control and hypoglycemic safety7

CGM and Glycemic Control

Page 6: Dexcom G4 PLATINUM HCP Brochure

Whether you’re trying to lower your patients’ A1c,

reduce their number of hypo events, or reduce glycemic

excursions, Dexcom Continuous Glucose Monitoring

(CGM) gives your patients a complete and real-time

picture of their glucose levels to help avoid these events.8

Fingersticks alone can only alert you to patterns when

you have tested. But with CGM, you’ll see where glucose

is heading and how fast it’s getting there. With the

Dexcom G4 PLATINUM, you can coach your patients

to make informed decisions in the short-term while

mapping a pathway for long-term better health.

Control

8.0

A1c

(%)

7.5

7.0

6.5Baseline 13 weeks 26 weeks

RT-CGM

P<.001

*Error bars stand for 95% Cl.

JDRF Continuous Glucose Monitoring Study Group. N Engl J Med. 2008;359(14):1464-1476

CGM Lowers A1Cs without increasing hypoglycemia

Significant Decrease in A1c in Patients Aged 25 Years

-0.53%

How CGM Helps Patients MakeHealthy, Well-Informed Decisions

CGM’s Effects on HypoglycemiaIntensive insulin treatment and lower A1C increase exposure to hypoglycemia, and this risk increases with

the duration of diabetes.9 The Battelino study below showed time spent in hypoglycemia below 63 mg/dL

was reduced in the continuous monitoring group, regardless of insulin delivery method (41%

reduction in pump users and 59% multiple daily injections users).10

1.0

0.8

0.6

0.4

0.2

Me

an T

ime

Sp

en

t <

63

mg

/dL

(ho

urs

/day

)

1.6

1.4

1.2

1 2 3 4 5 6

Continuous Monitoring Group

Control Group - Conventional SMBG

Month

With CGM, T1 patients can see both a reduction in time spent hypoglycemic

and HbA1c.9

Page 7: Dexcom G4 PLATINUM HCP Brochure

Setting an Even Higher Standard in CGM1

When it comes to accuracy, Dexcom’s Sensor Geometry, Membrane Technology, and Algorithm are what set

us apart. Our commitment to continuously improve our technology enables us to deliver exceptional sensing

performance. The results speak for themselves.

When LOWER is better

When HIGHER is better

Metrics presented are values rounded to the nearest whole number.

Overall AccuracyMean ARD (MARD)1 % of CGM-YSI

9%

Sensor to Sensor VariationAverage difference between sensors

9%

Hypoglycemia Detection Rate(% of time BG level at/below alert setting and

alert sounded within 15 minutes before or after BG value was 70 mg/dL)

91%

95%

Day 1: 91% Day 4: 95%Day 7: 97%

Avg Daily Calibration: 2x/day

Hypoglycemia Accuracy Over Time (% within 20 mg/dL when BG

is between 40-80 mg/dL)

Sensor Life(up to indicated use)

98%(7 day sensor)

Hypoglycemia Accuracy(within 20 mg/dL of YSI for CGM less than 80 mg/dL)

Page 8: Dexcom G4 PLATINUM HCP Brochure

Widespread Coverage for CGM The majority of commercial insurances have medical policy to cover CGM. Dexcom can help access insurance coverage for your patients.

Come Take a LookDexcom G4 PLATINUM Up Close

Color CGM TrendsEasy to read: yellow for

high, red for low, white

for good to go

Touch of a Button™ Nothing complicated – a

simple push of a button

shows where glucose is,

where it’s going, and how

fast it’s getting there

Trend arrows and

Rate-of-Change (ROC) Alerts Catch highs and lows before

they happen and how fast they’re

getting thereEasy Calibration*2 calibrations/day for

optimal accuracy

20-Feet TransmissionMore flexibility for your

patients’ active lifestyle

SensorTiny sensor wire for easy,

comfortable 7-day wear

Actual Size

Available in 3 ColorsChoose from Tickled Pink,

Classic Black and Ocean Blue

Customized Alerts Tones and melodies to

suit any environment

plus a hypo alarm set at

55 mg/dL

* At least 2 calibrations are required and more might be necessary.

Page 9: Dexcom G4 PLATINUM HCP Brochure

The Dexcom G4 PLATINUM was designed to be discreet,

comfortable, and lifestyle friendly.

At 2.4 ounces, Dexcom G4 PLATINUM is light, compact

and discreet. In addition to its portability, the G4 PLATINUM’s

large color LCD screen, complete with trend indication

arrows, makes viewing and interpretation effortless.

A smaller receiver provides discretion, but operational

comfort is the cornerstone of compliance. That’s why the

Dexcom G4 PLATINUM system uses an insertion needle

described as virtually painless.**

**dQ&A market research study, Q1-2010. Dexcom SEVEN Plus study. Dexcom G4 PLATINUM uses the same needle and applicator.

Discretion and comfort make daily Dexcom CGM an easy choice.

Increased consumable durability makes for easy maintenance.

With the longest FDA-approved sensor life available, patients

change sensors only once a week.

2.4oza fraction of the weight of most smart phones

7 dayslongest sensor life1

The Differenceis in the Design

Page 10: Dexcom G4 PLATINUM HCP Brochure

INTUITIVE. FOCUSED. SIMPLIFIED.

Identify - Prioritize - OptimizeDiabetes medical and lifestyle managementwith the full picture of CGM with Dexcom STUDIOTM

Discover the problem and solution with CGM. When you pinpoint the glycemic excursion with CGM,

applying the best therapy to solve those excursions can be simplified and Dexcom STUDIO brings the

‘road map’ of your patients to light.

Look for Patterns: Modal Day Report Assess Patterns and Variability All at Once: Hourly Stats Report

Assess Daily Nuances and Discuss Daily Diabetes Management Decisions: Glucose Trends

Identify Significant Glycemic Issues Quickly and Easily: Dexcom PORTRAIT™

Celebrate Successes: Success Report Understand the Quality of Glucose Control: Glucose Distribution Report

CPT Code 95251 for the interpretation of CGM Reports

Page 11: Dexcom G4 PLATINUM HCP Brochure

Dexcom, the CGM of Choice

Dexcom consistently ranked highest in

customer loyalty 5 years in a row11 and

won the Everyday Health Award for Emerging Tech in the

2014 Consumer Electronics Show!

2010 20112009

Sensor of choiceNo matter what your patients’ choice of insulin

delivery, CGM can benefit patients on multiple

daily injections just as significantly as those on

insulin pumps.12

If your patient pumps, Dexcom G4 PLATINUM

can be used to complement their insulin pump

to help fine-tune their insulin delivery therapy.

See for yourself what sets us apart and experience the difference that is Dexcom.

Contact us today at (888) 738-3646 / (858) 200-0200 or visit www.dexcom.com to discover more.

AP

2012 2013

Going beyondDexcom is the first to develop a CE Marked in-vivo, Automated Blood

Glucose Monitoring System in partnership with Edwards Lifesciences

for use in the critical care environment.+

+ CE marked, not for sale in US.

In the Artificial Pancreas arena,14 Dexcom CGM is a proud partner in

the JDRF AP and the European AP@Home studies.

Insulin & Pump Brands

Animas Asante Roche

Omnipod Medtronic13

Tandem Diabetes Care

Eli Lilly Sanofi

Novo Nordisk

Page 12: Dexcom G4 PLATINUM HCP Brochure

References:

1 Dexcom G4 PLATINUM User Guide, 2014.

2 Edward R. Damiano, Firas H. El-Khatib, Hui Zheng, David M. Nathan, Steven J. Russell, Boston, MA., 2013. Presented at the 73rd ADA Scientific Sessions.Reference is YSI (Yellow Springs Laboratory Instrument).

3 Yoo HJ, Park SY, Ryu OH, et al. Use of a real-time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes Diabetes Res Clin Pract. 2008 Oct;82 (1):73-9. doi:

10.1016/j.diabres.2008.06.015

4 Klonoff D, Buckingham B, et al. Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinolog & Metabolism. 2011 Oct; 96 (10): 2968-2979.

5 Beck RW, MD, Hirsch IB, Laffel L, Tamborlane WV, et al. Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 Diabetes. Diabetes Care. 2009 August; 32(8): 1378–1383

6 Bode BW, Schwartz S, Stubbs HA, Block JE: Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes. Diabetes Care 2005;28:2361–2366

7 T1D Exchange, February 2013

8 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. N Engl J Med.2008:359(14):1464

1476.

9 Shalitin S, Phillip M. Diabetes Care 2008;31(Suppl. 2):S121–S124.

10 Battelino T. et al. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. 11 dQ&A market research study, 2009-2013. 12 Rodbard D, Jovanovic L, Garg SK. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diab Tech

Ther. 2009;11:757-763 13 1 in 4 Dexcom users on pumps use Medtronic, Dexcom customer survey, April 2013 14 Internal data on file, May 2012.

Customer Care:

(888) 738-3646

Dexcom Inc. | Corporate Headquarters

6340 Sequence Drive

San Diego, CA 92121

(858) 200-0200

www.dexcom.com LBL012425 Rev01 MT22580

To locate your local Dexcom representative,

call (888) 738-3646

©2014 Dexcom Inc. All rights reserved. This product is covered by US patent. DEXCOM, THE GLUCOSE SENSOR COMPANY, DEXCOM G4 PLATINUM, DEXCOM STUDIO, DEXCOM PORTRAIT, DEXCOM MAKES SENSE., DAILY STRIP PRINT, DESIGNED FOR EXCEPTIONAL SENSING, QUICK PRINT, SMART.SIMPLE.SENSE., and TOUCH OF A BUTTON are trademarks and registered trademarks of Dexcom, Inc. All trade dress used in connection with Dexcom products and services appearing herein are property of Dexcom and protected by United States and foreign trademark laws. All other trademarks and registered trademarks are the property of their respective owners.

BRIEF SAFETY STATEMENT

The Dexcom G4 PLATINUM Continuous Glucose Monitoring System is a glucose monitoring device indicated for detecting trends and tracking patterns in persons (age 18 and older) with diabetes. CONTRAINDICATIONS: Remove the Dexcom G4 PLATINUM System before MRI, CT scan, or diathermy treatment. Taking acetaminophen while wearing the sensor may falsely raise your sensor glucose readings. WARNING: Do not use the Dexcom G4 PLATINUM for treatment decisions. The Dexcom G4 PLATINUM does not replace a blood glucose meter. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have infection or inflammation. Report broken sensors to Dexcom Technical Support. The Dexcom G4 PLATINUM is not approved for use in children or adolescents, pregnant women or persons on dialysis. Sensor placement is not approved for sites other than under the skin of the belly (abdomen). Contact Dexcom Toll Free at 877-339-2664 or www.dexcom.com for detailed indications for use and safety information.